6 results
Opioid Use Disorder Medications - Pharmacokinetics

Buprenorphine is a partial mu-opioid receptor agonist with low intrinsic activity,
in which higher doses ... the sublingual tablet ... #Opioid #UseDisorder ... #Comparison #Table ... #Pharmacology #
Inpatient Management of Opioid Use Disorder: Methadone vs Buprenorphine - Comparison Table

Some patients may decline buprenorphine
Buprenorphine - Comparison Table ... interested in medication ... Dosing usually begins ... formulation, the dose ... #UseDisorder #Addiction
Diabetes Mellitus Type 2 Inpatient Medication Guide

Classes: Biguanide, Sulfonylurea, TZD, DPP-4 inhibitor, GLP-1 receptor agonist, SGLT2i,
Type 2 Inpatient Medication ... Diabetes #Mellitus #DM2 ... #pharmacology # ... comparison #table ... #endocrinology
Rybelsus (oral semaglutide) - First Oral GLP-1 Agonist
Dosing:
3 mg daily x 30 days, then 7 mg
GLP-1 Agonist Dosing ... semaglutide, the same medication ... drug to remain stable ... semaglutide #Diabetes #Pharmacology ... #Endocrinology
Insulin Calculations for Type 1 Diabetes 

Insulin-to-Carb Ratio (ICR) 500/TDD = #g of carbs covered by
ICR) 500/TDD = #g ... calculations used in dosing ... Type1 #Diabetes #DM1 ... #Pharmacology # ... Endocrinology
Hyperkalemia - Diagnosis and Management - GrepMed Handbook

S/Sx: Most pts asymptomatic. Weakness, cramping, nausea, paresthesias, palpitations,
: K+, ACEi/ARBs, ... NSAIDs, β-blockers, Antibiotics ... (Bactrim, PCN G-K ... Elimination (see Table ... Transient, repeat dose